Evidence map›Paper›PMID 28275152›Full record

ArticleScience translational medicine2017

A semisynthetic

Benjamin Schumann, Heung Sik Hahm, Sharavathi G Parameswarappa, Katrin Reppe, Annette Wahlbrink, Subramanian Govindan, Paulina Kaplonek, Liise-Anne Pirofski, Martin Witzenrath, Chakkumkal Anish and 2 more

Abstract read
In one paragraph

Article in Science translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. A syntheticScience advances · 2026
    Article
  7. Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Review
  8. Synthesis of Fluorinated Glycotope Mimetics Derived fromInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Serum antibody screening using glycan arrays.Chemical Society reviews · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Benjamin SchumannMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany.ORCID 0000-0001-5504-0147
Heung Sik HahmMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany.ORCID 0000-0003-2326-7923
Sharavathi G ParameswarappaMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany.ORCID 0000-0003-2785-6063
Katrin ReppeDivision of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Annette WahlbrinkMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany.ORCID 0000-0002-0739-0748
Subramanian GovindanMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany.ORCID 0000-0002-8536-756X
Paulina KaplonekMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany.ORCID 0000-0001-9459-5946
Liise-Anne PirofskiDivision of Infectious Diseases, Department of Medicine, Montefiore Medical Center and Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Martin WitzenrathDivision of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-9787-5633
Chakkumkal AnishMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany.
Claney L PereiraMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany. peter.seeberger@mpikg.mpg.de claneylebev.pereira@vaxxilon.com.ORCID 0000-0003-1972-7907
Peter H SeebergerMax Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany. peter.seeberger@mpikg.mpg.de claneylebev.pereira@vaxxilon.com.ORCID 0000-0003-3394-8466
Max Planck Institute of Colloids and Interfaces · DECharité - Universitätsmedizin Berlin · DEAlbert Einstein College of Medicine · US

Funding

Effects of aging and HIV infection on the response to pneumococcal vaccineR01AG045044 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PIROFSKI, LIISE-ANNE · 2014 to 2018
$2.5M
Antibody immunity to serotype 3 Streptococcus pneumoniaeR56AI104234 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PIROFSKI, LIISE-ANNE · 2013 to 2013
$407k
NIAID NIH HHS R56 AI104234NIA NIH HHS R01 AG045044
6 · The paper itself

Abstract

Glycoconjugate vaccines based on capsular polysaccharides (CPSs) of pathogenic bacteria such as

Indexed as

SerogroupAnimalsAnti-Bacterial AgentsAntibodies, BacterialAntibodies, MonoclonalBacterial CapsulesFemaleFrameshift MutationGlycoconjugatesGlycomicsHL-60 CellsHumansMice, Inbred BALB CMice, Inbred C57BLPneumococcal VaccinesPolysaccharides13-valent pneumococcal vaccineAnti-Bacterial AgentsAntibodies, BacterialAntibodies, MonoclonalGlycoconjugatesPneumococcal VaccinesPolysaccharidesVaccines, Conjugate

Identifiers

PMID28275152
PMCPMC5573155
OpenAlexW2592211706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.